However, the discrepancy in the status of HIF1 expression in diabetic patients needs to dealt with further research to elaborate on its potential diagnostic and predictive role as a biomarker for breast cancer patients with diabetes. The gene discussed is HIF1A; the disease is diabetes mellitus.